Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounding Theme Archive
INFUSION AND STERILE PREPARATIONS
INFUSION AND STERILE PREPARATIONS
Online access to Journal articles and formulations within one or more related compounding topics.

  • Full-color, full-text PDF files of articles and formulations from the Journal.
  • Print or save articles for your research, marketing, and educational needs.
  • Log-in to your account for keyword or topical search and download.
  • Purchased items appear with download icon in contents and search results.

Only $20000


(Select Format)
Instant Online Access

This archive contains the following articles listed by volume, issue and page number:

INFUSION RELATED ARTICLES
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Calculations
Stockton Shelly J
Sep/Oct 2023
Pg. 410

Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Penoyer Daleen
, Giuliano Karen, Middleton Aurea
Mar/Apr 2023
Pg. 169-174

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags
Breukels Oscar
, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
Jul/Aug 2018
Pg. 345-349

U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
Nov/Dec 2016
Pg. 457-458

Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A
, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2016
Pg. 328-332

Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump
Tomasello Cristina
, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
Jul/Aug 2016
Pg. 343-346

Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Mody Vicky
, Shah Samit, Patel Jaymin, Thomas Michael C
May/Jun 2016
Pg. 236-238

Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment
Hecq Jean-Daniel
, Rolin Catherine, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Nov/Dec 2015
Pg. 521-524

In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Bhattacharya Sisir
, Parekh Satish, Dedhiya Mahendra
Sep/Oct 2015
Pg. 432-436

Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Puertos Enrique
, Spencer Melissa
Jul/Aug 2015
Pg. 334-336

Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
Jul/Aug 2014
Pg. 313-317

Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion
Allen Loyd V Jr
Nov/Dec 2011
Pg. 504

Home Infusion: Overview of the Infusion Patient-Care Process
Kennedy Steve
Jul/Aug 2011
Pg. 270-276

Stability of Ertapenem in an Elastomeric Infusion Device
Phipps Stephen D
, Peacock Gina F, Smith Douglas L
May/Jun 2011
Pg. 252-254

Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations
Jasti Bhaskara R
, Saraf Poonam
May/Jun 2011
Pg. 259-261

Home Infusion: Available Vascular Access Devices and Common Therapies
Kennedy Steve
, Williams LaVonn A
May/Jun 2011
Pg. 183-188

Home Infusion Basics for the Non-Infusion Pharmacist
Miron Karen E
Mar/Apr 2011
Pg. 94-100

Home Infusion Accreditation: Another Quality Recognition Branding Tool
Canally Sandra C
Sep/Oct 2010
Pg. 360-364

Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device
Tsiouris Maria
, Ulmer Marisa, Yurcho James F, Hooper Kevin L, Gui Min
Sep/Oct 2010
Pg. 436-439

Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C
, Ben Michel, Trusley Craig, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173

Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate
Trissel Lawrence A
, Zhang Yanping
Sep/Oct 2004
Pg. 398-403

Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags
Gupta Vishnu D
Sep/Oct 2004
Pg. 404-406

A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W
, Trissel Lawrence A
Jul/Aug 2004
Pg. 251-263

Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours.
Musami Patrick
, Stewart James T, Taylor E Will
May/Jun 2004
Pg. 236-239

Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2004
Pg. 136

Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion
Gupta Vishnu D
Mar/Apr 2004
Pg. 153-155

Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags
Lebrun John
, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
Mar/Apr 2004
Pg. 156-159

PostScription: Cleanroom Standards
Fitzpatrick Mike
, Goldstein Ken
Mar/Apr 2004
Pg. 160

Hydrochloric Acid 0.1-N Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 55

Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours
Musami Patrick
, Stewart James T, Taylor E Will
Jan/Feb 2004
Pg. 73-76

Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
Jul/Aug 2003
Pg. 310-312

Phenytoin Injections: From Compounding to Cerebyx
Newton David W
Nov/Dec 2002
Pg. 410-413

Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1
Chamallas Stanley N
, Sullivan Kathleen
Nov/Dec 2002
Pg. 428-432

Total Parenteral Nutrition for Animals
Sammarco Domenic A
Sep/Oct 2002
Pg. 328-330

A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
Mar/Apr 2002
Pg. 120-122

Creating a Productivity Measurement Tool for a Home Infusion Pharmacy
Chamallas Stanley N
Jan/Feb 2002
Pg. 24-26

New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems
Kastango Eric S
, Hadaway Lynn
Jan/Feb 2002
Pg. 55-57

Ceftazidime 20-mg/mL for Ambulatory Infusion Pump
Allen Loyd V Jr
Nov/Dec 2001
Pg. 451

New Perspectives on Vancomycin Use in Home Care, Part 1
Kastango Eric S
, Hadaway Lynn
Nov/Dec 2001
Pg. 465-469

Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L
, Stewart James T, Warren Flynn W
Sep/Oct 2001
Pg. 394-396

Assessment of the Stability of Teicoplanin in Intravenous Infusions
Galanti Laurence M
, Hecq Jean-Daniel, Jeuniau Philippe, Vanbeckbergen Danielle, Jamart Jacques
Sep/Oct 2001
Pg. 397-400

PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor
Gupta Vishnu D
Jul/Aug 2001
Pg. 328

Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A
, Williams Kimberly Y, Baker Ma
Jan/Feb 2001
Pg. 69-73

Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
, Ling Jie
Jan/Feb 2001
Pg. 73-75

Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
, Ling Jie
Jan/Feb 2001
Pg. 75-77

Disposable Ambulatory Infusion Devices: A Review - Part 3
Ashworth Lisa D
Nov/Dec 2000
Pg. 442-443

Ambulatory Syringe Infusion Devices: A Review - Part 2
Ashworth Lisa D
Sep/Oct 2000
Pg. 364

Short Communication: Compounding for Implantable Pumps
Molitor Richard
Jul/Aug 2000
Pg. 280

Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Ashworth Lisa D
Jul/Aug 2000
Pg. 281-285

Needleless Infusion Systems
Allen Loyd V Jr
, Mathews Elizabeth
May/Jun 2000
Pg. 183

Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration
Inagaki Kazuhiro
, Miyamoto Yuriko, Kurata Niroko, Nakane Shigeki, Gill Mark A, Nishida Mikio
Mar/Apr 2000
Pg. 150-153

Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection
Gupta Vishnu D
, Bailey RE
Jan/Feb 2000
Pg. 66-68

Electronically Controlled Drug Delivery
Kloesel Lawson
Nov/Dec 1999
Pg. 439-440

Compounding Radiolabeled Blood Cells for Diagnostic Imaging
Hinkle George H
Nov/Dec 1999
Pg. 443-446

Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C
Webster Andrew A
, English Brett A, McGuire J Michael, Riggs Robert M, Lander Vickie, Buckle Thomas
Sep/Oct 1999
Pg. 412-414

Catheter Occlusion: Causes and Solutions
McKinnon Barbara
, Lima Hetty A
Sep/Oct 1998
Pg. 342-346

TPN Bulk Compounding from Bulk Drug Substances
Chamallas Stanley N
Sep/Oct 1998
Pg. 347-349

The Feasibility and Benefits of TPN in Horses: A Review of the Findings
Paoletti James E
, Downing Dee, Tormo Vicente J
Sep/Oct 1998
Pg. 351-353

Model Parenteral Nutrition Formulation (Veterinary)
Allen Loyd V Jr
Sep/Oct 1998
Pg. 352

Required Documentation for Home Infusion Pharmacies - Compounding Records
Lima Hetty A
Sep/Oct 1998
Pg. 354-359

Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids
Allen Loyd V Jr
Sep/Oct 1998
Pg. 366

Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids
Allen Loyd V Jr
Sep/Oct 1998
Pg. 367

Three-in-One Adult Total Parenteral Nutrition
Allen Loyd V Jr
Sep/Oct 1998
Pg. 371

Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump
Xu Quanyun A
, Trissel Lawrence A
Sep/Oct 1998
Pg. 382-384

Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers Solutions
Sarver Jeffrey G
, Pryka Randy, Alexander Kenneth S, Weinstein Louis, Erhardt Paul W
Sep/Oct 1998
Pg. 385-388

Cleaning, Inspecting and Flow-Accuracy Testing of Ambulatory Pumps
Allen Loyd V Jr
Nov/Dec 1997
Pg. 430-431

Home Infusion and Alternative-Site Health Care: The Big Picture
Lima Hetty A
Sep/Oct 1997
Pg. 294-297

Continued Growth Predicted for Home Infusion Market
Allen Loyd V Jr
Sep/Oct 1997
Pg. 298

Drug Stability and Compatibility: Special Considerations for Home Health Care
Lima Hetty A
Sep/Oct 1997
Pg. 301-305

Ambulatory Infusion Pump Review
Allen Loyd V Jr
Sep/Oct 1997
Pg. 306-307

Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures
Fausel Christopher A
, Newton David W, Driscoll David F, Allen Loyd V Jr
Jan/Feb 1997
Pg. 54-59

Return to Top

STERILE PREPARATIONS RELATED ARTICLES
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing
Akers Michael J
May/Jun 2024
Pg. 229-240

Sterile Filtration
Akers Michael J
Mar/Apr 2024
Pg. 120-127

Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S
, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jan/Feb 2024
Pg. 44-55

Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Allen Loyd V Jr
Nov/Dec 2023
Pg. 483-486

Hyaluronidase Injection
Allen Loyd V Jr
Nov/Dec 2023
Pg. 491

Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
Sep/Oct 2023
Pg. 397-409

Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
Jul/Aug 2023
Pg. 305-313

Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
May/Jun 2023
Pg. 223-229

Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility
Summers Amy
Mar/Apr 2023
Pg. 114-121

Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
Mar/Apr 2023
Pg. 123-139

Aminohippurate Sodium 250 mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2023
Pg. 142

Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes
de Wilde Sofieke
, Crul Mirjam, Breukels Oscar
Mar/Apr 2023
Pg. 154-159

Sterile Basics: How to Know if Your Cleanroom Can Consistently Operate Within a State of Control
Summers Amy
, Stephens Pat
Jan/Feb 2023
Pg. 39-46

Sterile Basics of Compounding: Contamination Control Strategies, Part 2
Summers Amy
Nov/Dec 2022
Pg. 497-504

Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding)
Allen Loyd V Jr
Nov/Dec 2022
Pg. 515

Sterile Basics of Compounding: Contamination Control Strategies, Part 1
Summers Amy
Sep/Oct 2022
Pg. 411-418

Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
Jul/Aug 2022
Pg. 309-315

Three Things You Need to Know Right Now
Brunner Scott
May/Jun 2022
Pg. 211-213

Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
May/Jun 2022
Pg. 219-228

Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Catry Emilie
, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
May/Jun 2022
Pg. 248-254

Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
Mar/Apr 2022
Pg. 118-126

Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation
Allen Loyd V Jr
Mar/Apr 2022
Pg. 129-136

Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience
Mohammad Insaf
, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
Jan/Feb 2022
Pg. 10-17

Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
Jan/Feb 2022
Pg. 41-49

Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021
Hecq Jean-Daniel
, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Nov/Dec 2021
Pg. 446-462

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O
, Prudom Melanie J, Summers Amy
Sep/Oct 2021
Pg. 389-395

Expecting the Expected: Planning Considerations for Cleanroom Construction
Roberts Patricia A
, Kroon Laura
Jul/Aug 2021
Pg. 276-281

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O
, Prudom Melanie J, Summers Amy
Jul/Aug 2021
Pg. 298-302

Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317

Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding
Zamani Mazdak
, Chan Kayin, Wilcox Julie
May/Jun 2021
Pg. 182-186

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 92

Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Roberts Patricia A
, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Mar/Apr 2021
Pg. 109-113

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
McKettrick Greg
, Yoch Doug
Jan/Feb 2021
Pg. 18-23

Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 42

Establishing a Structured Pharmacy Training Program in Sterile Compounding
Dirbas Muhannad
, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
Nov/Dec 2020
Pg. 460-465

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478

Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients
Nogales Luis Marcos
, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
Sep/Oct 2020
Pg. 358-364

Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse)
Allen Loyd V Jr
Sep/Oct 2020
Pg. 406

Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques
Bjornstad Matthew
, Kosinski Tracy, Burlage Robert
Sep/Oct 2020
Pg. 434-438

Quality Control: Rapid Sterility Testing for Compounding Pharmacies
Taylor Andrew
Jul/Aug 2020
Pg. 299-303

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
Jul/Aug 2020
Pg. 305-309

Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review
Milibari Loay
, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter
Jul/Aug 2020
Pg. 346-351

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
May/Jun 2020
Pg. 215-220

Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
Mar/Apr 2020
Pg. 121-126

How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Vaughn Stacey R
, Radwick Allison
Jan/Feb 2020
Pg. 14-19

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Mulder Kyle
Nov/Dec 2019
Pg. 447-452

How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A
, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019
Pg. 454-461

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019
Pg. 467-471

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2019
Pg. 387-391

Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
Sep/Oct 2019
Pg. 399-402

Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
Jul/Aug 2019
Pg. 299-303

Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
May/Jun 2019
Pg. 221-228

Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website
Sluggett Janet K
, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
May/Jun 2019
Pg. 238-244

Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
Mar/Apr 2019
Pg. 123-130

Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Martin Matt
Jan/Feb 2019
Pg. 47-49

Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
Martin Matt
Nov/Dec 2018
Pg. 475-478

Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina
, Baskett Dustin
Sep/Oct 2018
Pg. 387-398

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

Cysteamine 0.5% Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2018
Pg. 408

Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
Jul/Aug 2018
Pg. 303-312

Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding
Allen Loyd V Jr
May/Jun 2018
Pg. 206-217

Dorzolamide 2% Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2018
Pg. 234

Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
May/Jun 2018
Pg. 237

Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Rhoads Rick
Mar/Apr 2018
Pg. 129-134

Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution
Allen Loyd V Jr
Mar/Apr 2018
Pg. 147

Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture
Allen Loyd V Jr
Mar/Apr 2018
Pg. 151

Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy
Kosinski Tracy M
, Brown Michael C, Zavala Pedro J
Jan/Feb 2018
Pg. 41-46

Glutamate and Aspartate Cardioplegia Additive Solution
Allen Loyd V Jr
Jan/Feb 2018
Pg. 50

Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
Jan/Feb 2018
Pg. 57

Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2017
Pg. 493

Trace Elements Injection 5
Allen Loyd V Jr
Nov/Dec 2017
Pg. 498

Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2017
Pg. 499

Basics of Sterile Compounding: Particulate Matter
Akers Michael J
Sep/Oct 2017
Pg. 395-404

Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
Sep/Oct 2017
Pg. 408

Etoposide 20-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 410

Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 411

Ioversol Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 413

Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose
Allen Loyd V Jr
Sep/Oct 2017
Pg. 415

Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2017
Pg. 416

Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes
Kirkham Kylian
, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Sep/Oct 2017
Pg. 426-429

Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen
, Hohlfelder Benjamin, Szumita Paul M
Sep/Oct 2017
Pg. 436-439

Component Selection for Sterile Compounding
Dilzer Richard H
Jul/Aug 2017
Pg. 277-280

Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
Jul/Aug 2017
Pg. 301-308

Reteplase Injection
Allen Loyd V Jr
Jul/Aug 2017
Pg. 317

Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 319

Torsemide 10-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2017
Pg. 320

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding
Ligugnana Roberto
May/Jun 2017
Pg. 182-190

Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William
, Roth Abby
May/Jun 2017
Pg. 193-203

Basics of Sterile Compounding: Manipulating Peptides and Proteins
Akers Michael J
May/Jun 2017
Pg. 223-228

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

Accuracy Considerations in Sterile Compounding
Akers Michael J
Mar/Apr 2017
Pg. 133-142

Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers
McCluskey Susan V
, Kirkham Kylian, Munson Jessica M
Mar/Apr 2017
Pg. 150-153

Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
Jan/Feb 2017
Pg. 47-56

Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 62

Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 64

Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500

Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2016
Pg. 509

Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404

Inamrinone 5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2016
Pg. 408

Tromethamine Injection
Allen Loyd V Jr
Sep/Oct 2016
Pg. 415

Choosing a Vial Processing Line for Aseptic Compounding: Part 1
Noorian Shaun
, Vahedi Navid
Jul/Aug 2016
Pg. 283-292

Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding
Akers Michael J
Jul/Aug 2016
Pg. 307-314

Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2016
Pg. 318

Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 319

Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 325

Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 326

Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
May/Jun 2016
Pg. 217-222

Carboplatin 50-mg/mL Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 226

Cefotetan Disodium Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 227

Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
May/Jun 2016
Pg. 228

Sodium Nitroprusside 25-mg/mL Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 234

Root Cause Analysis, Part 2: Sterile Compounding
Cabaleiro Joe
, Jackson Kathleen
Mar/Apr 2016
Pg. 99-104

Formulation and Stability of Solutions
Akers Michael J
Jan/Feb 2016
Pg. 41-45

Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
Jan/Feb 2016
Pg. 51

Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
Jan/Feb 2016
Pg. 54

Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 55

Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 56

Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
Nov/Dec 2015
Pg. 491-500

Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2015
Pg. 505

Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2015
Pg. 506

Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
Nov/Dec 2015
Pg. 507

Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
Nov/Dec 2015
Pg. 509

Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
Nov/Dec 2015
Pg. 510

Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Donnelly Ronald F
Sep/Oct 2015
Pg. 383-386

Sterile Filtration
Akers Michael J
Sep/Oct 2015
Pg. 393-401

Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S
, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jul/Aug 2015
Pg. 268-278

Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing
Akers Michael J
Jul/Aug 2015
Pg. 315-320

Ammonium Molybdate 25-mcg/mL Injection
Allen Loyd V
Jul/Aug 2015
Pg. 324

Cytarabine 50-mg/mL Injection
Allen Loyd V
Jul/Aug 2015
Pg. 328

Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection
Allen Loyd V
Jul/Aug 2015
Pg. 329

Oxytocin 10-units/mL Injection
Allen Loyd V
Jul/Aug 2015
Pg. 330

Phytonadione 2-mg/mL Injection
Allen Loyd V
Jul/Aug 2015
Pg. 331

Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities
Weller Tom
, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan
May/Jun 2015
Pg. 182-192

Quality Assurance and Quality Control, Part 2
Akers Michael J
May/Jun 2015
Pg. 215-221

Basics of Sterile Compounding: Contamination Control
Akers Michael J
May/Jun 2015
Pg. 232-238

Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
May/Jun 2015
Pg. 246

Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
May/Jun 2015
Pg. 247

Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis
, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
May/Jun 2015
Pg. 252-260

Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia
, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
May/Jun 2015
Pg. 261-267

New England Compounding Center Indictment
Cabaleiro Joe
Mar/Apr 2015
Pg. 94-102

Quality Assurance and Quality Control, Part 1
Akers Michael J
Mar/Apr 2015
Pg. 121-124

Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing
Akers Michael J
Mar/Apr 2015
Pg. 127-138

Aminohippurate Sodium 200-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 143

L-Cysteine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 146

Morrhuate Sodium 5% Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 147

Pancuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 149

Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 150

Trypan Blue 0.06% Ophthalmic Solution
Allen Loyd V Jr
Mar/Apr 2015
Pg. 151

Basics of Sterile Compounding: Aseptic Processing
Akers Michael J
Jan/Feb 2015
Pg. 49-56

Cisplatin 1-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 62

Daunorubicin 5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 63

Erythromycin 50-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 64

Hydralazine Hydrochloride 20-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 65

Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 69

PreScription: "Named Formulas" Database Available
Allen Loyd V Jr
Nov/Dec 2014
Pg. 444

Depyrogenation Options for the Compounding Cleanroom
Weller Tom
, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce
Nov/Dec 2014
Pg. 446-454

Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
Nov/Dec 2014
Pg. 479-484

Dexmedetomidine 100 mcg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 495

Leucovorin 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 497

Levocarnitine 200-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 498

Methylene Blue 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 500

Oxacillin Sodium 167-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 502

Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Palma Elisabetta
, Bufarini Celestino
Sep/Oct 2014
Pg. 358-364

Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know
Lanze Amanda
, Rudner Shara
Sep/Oct 2014
Pg. 397-399

Azithromycin 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 408

Dexpanthenol 250-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 410

Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 411

Fluorescein 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 412

Indocyanine green 2.5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 413

Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Johnson Kain
, Sully Andrew, Anthenat Bruce
Jul/Aug 2014
Pg. 270-276

Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
Jul/Aug 2014
Pg. 313-317

Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
Jul/Aug 2014
Pg. 322

Calcitriol 1-mcg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 324

Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 325

Indigo Carmine Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 329

Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 330

Zinc 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 331

Bupivacaine Hydrochloride 0.5% Injection
Allen Loyd V Jr
May/Jun 2014
Pg. 234

Lidocaine Hydrochloride 1% Injection
Allen Loyd V Jr
May/Jun 2014
Pg. 237

A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
Mar/Apr 2014
Pg. 94-99

Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole
, Nguyen Devin, Kupiec Thomas C
Mar/Apr 2014
Pg. 123-130

Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume
Allen Loyd V Jr
Mar/Apr 2014
Pg. 131-134

Fludarabine Phosphate 25-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 143

Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 144

Methylprednisolone 40-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 145

Polymixin B Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 146

Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 147

Selenium 40-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 149

Sincalide 1-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 150

Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 151

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12

Determination of Risk for Sterile Preparations
Freedman ben-Horin Shimon
, Rousso Tamaro
Jan/Feb 2014
Pg. 30-34

Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding
Hyde Tiffany D
Jan/Feb 2014
Pg. 46-52

Basics of Sterile Compounding: Bubble Point Testing
Thoma Laura
Jan/Feb 2014
Pg. 54-57

Aztreonam Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 60

Bumetanide 0.25-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 61

Droperidol 2.5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 62

Potassium Chloride 2-mEq/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 67

Procainamide Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 68

Vasopressin 20-units/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 69

Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies
Brensel Robert
, Brensel Scott, Ng Amy
Nov/Dec 2013
Pg. 465-475

Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 498

Cefazolin 250-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 499

Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2013
Pg. 502

Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 503

Compounding Pharmacies: Before and After an Inspection
Kulkarni Darshan
, Ricketts Samantha
Sep/Oct 2013
Pg. 358-362

Acyclovir 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 414

Aminocaproic Acid 250-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 415

Clindamycin 150-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 416

Fluorouracil 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 417

Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 418

Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 419

Mesna 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 420

Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 421

Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 422

Terbutaline Sulfate 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 423

United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Newton David W
Jul/Aug 2013
Pg. 283-288

Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
Jul/Aug 2013
Pg. 307-311

Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 328

Amikacin Sulfate 250-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 329

Dacarbazine 200-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 330

Ketamine 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 331

Methohexital Sodium 500-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 332

Metoprolol Tartrate 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 333

Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 335

Decontamination Technology: The Missing Element
Rahe Hank
May/Jun 2013
Pg. 193-199

Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines
Weatherman Kara D
, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
May/Jun 2013
Pg. 238-246

Sterilization of Compounded Parenteral Products: Verification of Autoclaves
Rahe Hank
Mar/Apr 2013
Pg. 94-98

Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Griffiths Tricia
, Connors Anne
Mar/Apr 2013
Pg. 130-134

Basics of Compounding: Repackaging, Part 2
Allen Loyd V Jr
Mar/Apr 2013
Pg. 136-140

Adenosine 3-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 144

Alcohol Dehydrated Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 145

Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate
Allen Loyd V Jr
Mar/Apr 2013
Pg. 147

Cyanocobalamin 1000-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 148

Dexrazoxane 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 149

Meropenem 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 150

Paclitaxel 6-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 151

Thiotepa 15-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 152

Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings
Weatherman Kara D
, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
Mar/Apr 2013
Pg. 168-174

Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
Jan/Feb 2013
Pg. 54-60

Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 64

Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 65

Granisetron 1-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 66

Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 67

Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 68

Milrinone 0.2-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 69

Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 70

Nicardipine Hydrochloride Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 71

Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 72

Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 73

Aminophylline 25-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 500

Ammonium Chloride 5-mEq/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 501

Azathioprine 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 502

Copper 0.4-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 503

Dipyridamole 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 504

Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 505

Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Allen Loyd V Jr
Nov/Dec 2012
Pg. 506

Papaverine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 507

Valproate Sodium 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 508

Vercuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 509

Metronidazole 5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 425

Doxapram Hydrochloride 20-mg/mL injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 418

Enalaprilat 1.25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 419

Esmolol Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 420

Fluconazole 2-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 421

Haloperidol 50-mg/mL in Oil Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 422

Meperidine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 423

Methocarbamol 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 424

Nalbuphine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 426

Oxymorphone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 427

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
McElhiney Linda F
May/Jun 2012
Pg. 190-195

PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone
Cabaleiro Joe
Jan/Feb 2012
Pg. 86-87

Misinterpretation of United States Pharmacopeia Chapter <797>
McElhiney Linda F
Jan/Feb 2012
Pg. 6-10

Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons
James Kate
, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
Sep/Oct 2011
Pg. 390-407

Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions
Schnatz Rick
, Hernandex-Cardoso Antonio
May/Jun 2011
Pg. 224-232

Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1
Latta Kenneth S
, Cabaleiro Joe, Whitehead Paul, Edison Doug
Mar/Apr 2011
Pg. 133-144

PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals
Allen Loyd V Jr
, Menighan Thomas E
Jan/Feb 2011
Pg. 4

A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management
Robinson Marian
Jan/Feb 2011
Pg. 20-26

Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations
Cooper James F
Jan/Feb 2011
Pg. 49-54

Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2
Cooper James F
, Chakrabarty Kaushik, McGuire Jason, Zolner William J, Jones Vann, Hedman Hilary
Nov/Dec 2010
Pg. 493-506

Home Infusion: Overcoming the Barriers to Entry
Franklin David M
Nov/Dec 2010
Pg. 450-455

Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device
Kennedy Steve
, Siefert Lisa Linn, Lange Matt
Sep/Oct 2010
Pg. 370-372

Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1
Dubczak John
, Latta Kenneth S, Hedman Hilary, Smith Donald R
Sep/Oct 2010
Pg. 407-414

PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board
Pharmacy Compounding Accreditation Board
Sep/Oct 2010
Pg. 440-441

PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals
Menighan Thomas E
Jul/Aug 2010
Pg. 268

Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
Jul/Aug 2010
Pg. 270-274

Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters
Dawson Michael E
Jul/Aug 2010
Pg. 317-320

Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C
, Allen Loyd V Jr
Jul/Aug 2010
Pg. 328-331

Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C
, Allen Loyd V Jr
May/Jun 2010
Pg. 232-238

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2010
Pg. 142-149

Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector
Khondkar Dristi
, Chopra Poonam, McArter John P, Rosen Joseph A, Li S Kevin
Mar/Apr 2010
Pg. 160-164

Ophthalmic Toning-Lubricating Drops
Allen Loyd V Jr
Jan/Feb 2010
Pg. 70

An Academic Practice Partnership: An Innovative Course in Advanced Compounding
Hale Katherine S
, Hammer Dana P, Needham Shawn, Lawhorn Michelle Gaster
Jan/Feb 2010
Pg. 48-53

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control
Okeke Claudia C
, Allen Loyd V Jr
Jan/Feb 2010
Pg. 60-64

Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Mixon William
, Angelle Patricea (Patsy), Chang Richard I
Nov/Dec 2009
Pg. 506-515

Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana
, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Nov/Dec 2009
Pg. 540-543

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures
Okeke Claudia C
, Allen Loyd V Jr
Nov/Dec 2009
Pg. 546-553

Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes
Bailey Caroline
, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole
Nov/Dec 2009
Pg. 564-568

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing
Okeke Claudia C
, Allen Loyd V Jr
Sep/Oct 2009
Pg. 420-426

Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients
Mixon Bill
, Ille Gary
Jul/Aug 2009
Pg. 290-294

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)
Okeke Claudia C
, Allen Loyd V Jr
Jul/Aug 2009
Pg. 322-329

PostScription: Compounding Pharmacy in Puerto Rico
Lopez Marisol
Jul/Aug 2009
Pg. 350-351

Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting
McElhiney Linda F
Jul/Aug 2009
Pg. 300-310

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2009
Pg. 234-238

Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797>
McElhiney Linda F
Mar/Apr 2009
Pg. 94-98

Tips for Cleanroom Construction and Renovation
Mixon William
, Huffman Lanny
Mar/Apr 2009
Pg. 100-104

Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations
Latta Kenneth S
, Howard Betty, Gordon Ken, Foster Lisa, Nichols Larry, Floyd Dan B, Winters Martell, Bryans Trabue
Mar/Apr 2009
Pg. 106-119

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2009
Pg. 146-150

Acidified Sodium Hypochlorite for Antisepsis and Disinfection
Allen Loyd V Jr
Mar/Apr 2009
Pg. 152

Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
Jan/Feb 2009
Pg. 53-55

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr
, Okeke Claudia C
Jan/Feb 2009
Pg. 56-62

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2008
Pg. 440-443

Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
Nov/Dec 2008
Pg. 524-528

Glycerin, Sterile
Allen Loyd V Jr
Nov/Dec 2008
Pg. 542

Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale
Okeke Claudia C
, Newton David W, Kastango Eric S, Allen Loyd V Jr
Nov/Dec 2008
Pg. 530-536

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr
, Okeke Claudia C
Jul/Aug 2008
Pg. 344-353

Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists
Mixon Bill
, Cabaleiro Joe, Latta Kenneth S, Vail Jane
Jul/Aug 2008
Pg. 321-327

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2008
Pg. 252-257

Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
May/Jun 2008
Pg. 216-229

Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony
, Fakata Keri, Stuart William
May/Jun 2008
Pg. 200-207

Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm!
Odegard Russell D
Mar/Apr 2008
Pg. 130-135

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2008
Pg. 136-144

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations
Allen Loyd V Jr
, Okeke Claudia C
Jan/Feb 2008
Pg. 54-60

Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study
Peters Gregory F
, McKeon Marghi R, Nerbun Richard G
Nov/Dec 2007
Pg. 450-470

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics
Allen Loyd V Jr
, Okeke Claudia C
Nov/Dec 2007
Pg. 492-499

Calculations: High-Technology Compounding and Investigational Dispensing
Webb Sheldon D
, Stockton Shelly J
Nov/Dec 2007
Pg. 500-501

Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance
Allen Loyd V Jr
Nov/Dec 2007
Pg. 502-503

Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Kupiec Thomas C
Sep/Oct 2007
Pg. 400-403

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2007
Pg. 404-410

Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
Jul/Aug 2007
Pg. 328

Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
Jul/Aug 2007
Pg. 302-305

Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2
Allen Loyd V Jr
, Okeke Claudia C
Jul/Aug 2007
Pg. 314-323

Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
Jul/Aug 2007
Pg. 335

Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2007
Pg. 230-236

Quality Control Analytical Methods: The Quality of Sterility Testing
McGuire Jason
, Kupiec Thomas C
Jan/Feb 2007
Pg. 52-55

BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Benischek Rita L
Nov/Dec 2006
Pg. 428-433

Quality-Control Analytical Methods: Sterility Failure Investigations
Venti Eden M
Sep/Oct 2006
Pg. 372-375

Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces
Acosta W Renee
, Salzman Robert D
Jul/Aug 2006
Pg. 277-280

Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist
Zolner William J
Jul/Aug 2006
Pg. 281-284

Aseptic Compounding in New Zealand and the Use of Still Air Boxes
Gargiulo Derryn
, Kairuz Therese Eileen
Jul/Aug 2006
Pg. 293-295

Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations
Douglass Kate
Jul/Aug 2006
Pg. 253-261

Putting the Science Back into the "Art and Science" of Compounding
Kastango Eric S
Jul/Aug 2006
Pg. 263-268

Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Reed-Kane Dana
, Kirshbaum Karen
May/Jun 2006
Pg. 165-171

Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor
Fields Shannon W
May/Jun 2006
Pg. 172

Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?
Tran Tuan
, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006
Pg. 202-204

Standard Operating Procedure: Sterility Test for Ophthalmic Solutions
Allen Loyd V Jr
May/Jun 2006
Pg. 218

Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2
Wagner James T
May/Jun 2006
Pg. 208-211

Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist
Jeffrey Megan
Mar/Apr 2006
Pg. 113-119

Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations
Dawson Michael F
Jan/Feb 2006
Pg. 36-39

How'd They Do That?
Roberts Jerrod L
Jan/Feb 2006
Pg. 46-49

Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management
Nguyen-Xuan Tho
, Griffiths William, Kern Christian, Van Gessel Elisabeth, Bonnabry Pascal
Jan/Feb 2006
Pg. 69-73

Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2005
Pg. 390

Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2005
Pg. 394

Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary)
Allen Loyd V Jr
Sep/Oct 2005
Pg. 395

Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Newton David W
Mar/Apr 2005
Pg. 127-130

PostScription: Experts Everywhere
Rahe Hank
Mar/Apr 2005
Pg. 167

USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing
Caputo Ross A
, Huffman Anne, Reich Robert
Jan/Feb 2005
Pg. 11-13

Using ACDs in the Practice of Pharmacy
Kastango Eric S
Jan/Feb 2005
Pg. 15-21

USP Chapter <797> and Preparing for a JCAHO Survey
McElhiney Linda F
Jan/Feb 2005
Pg. 23-28

Questions and Answers: USP Chapter <797> and JCAHO Compliance
Allen Loyd V Jr
Jan/Feb 2005
Pg. 29-31

A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In?
Vandenbroucke Johan
, Rahe Hank
Jan/Feb 2005
Pg. 33-35

Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations
Kupiec Thomas C
Jan/Feb 2005
Pg. 47-49

Barrier Isolators, Isolators, and Glove Boxes--What's the Difference?
Rahe Hank
Jan/Feb 2005
Pg. 53-56

Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2004
Pg. 466-467

Calculations
Prince Shelly J
Nov/Dec 2004
Pg. 468

Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2004
Pg. 479-485

Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating
Kastango Eric S
Sep/Oct 2004
Pg. 393-397

PreScription - Categories of Pharmaceutial Compounding
Allen Loyd V Jr
Jul/Aug 2004
Pg. 242

A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W
, Trissel Lawrence A
Jul/Aug 2004
Pg. 251-263

Clonidine HCl 1.5-mg/mL Injection
Allen Loyd V Jr
May/Jun 2004
Pg. 216

Fluorouracil 1% Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2004
Pg. 217

Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection
Allen Loyd V Jr
May/Jun 2004
Pg. 220

Testosterone Propionate 100-mg/mL in Oil Injection
Allen Loyd V Jr
May/Jun 2004
Pg. 222

Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs.
Xu Quanyun A
, Trissel Lawrence A, Pham Lien
May/Jun 2004
Pg. 228-230

Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Trissel Lawrence A
, Zhang Yanping
May/Jun 2004
Pg. 231-235

Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours.
Musami Patrick
, Stewart James T, Taylor E Will
May/Jun 2004
Pg. 236-239

Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Rahe Hank
Mar/Apr 2004
Pg. 89-94

Netilmicin 0.455% Ophthalmic Solution
Allen Loyd V Jr
Mar/Apr 2004
Pg. 138

Pyridoxine HCl 100-mg/mL Injection, Preservative Free
Allen Loyd V Jr
Mar/Apr 2004
Pg. 139

Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion
Gupta Vishnu D
Mar/Apr 2004
Pg. 153-155

Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags
Lebrun John
, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
Mar/Apr 2004
Pg. 156-159

PostScription: Cleanroom Standards
Fitzpatrick Mike
, Goldstein Ken
Mar/Apr 2004
Pg. 160

Glycerin 50% Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 54

Hydrochloric Acid 0.1-N Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 55

Phenol 5%-in-Oil Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 57

Vancomycin HCl and Heparin Sodium Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 60

Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours
Musami Patrick
, Stewart James T, Taylor E Will
Jan/Feb 2004
Pg. 73-76

Containment of Hazardous Particulates in the Compounding Pharmacy
Allen Loyd V Jr
Jul/Aug 2003
Pg. 281-285

Stability of Amikacin Sulfate in AutoDose Infusion System Bags
Zhang Yanping
, Trissel Lawrence A
May/Jun 2003
Pg. 230-232

Autoclaves for the Sterilization of Compounded Parenteral Products
Rahe Hank
Mar/Apr 2003
Pg. 114-116

Technology Spotlight: Barrier Isolators
Moussa Magdy
, Rahe Hank, Lo Katharine
Jan/Feb 2003
Pg. 42-43

Comparison of Endotoxin Testing Methods for Pharmaceutical Products
Joiner Timothy J
, Kraus Paul F, Kupiec Thomas C
Nov/Dec 2002
Pg. 408-409

View Sample
Book Review: Sterile Compounding
Reed-Kane Dana
Nov/Dec 2002
Pg. 414

Sterile Compounding of Respiratory Inhalation Solutions
Roberts Rob
, Moore Eddie
Nov/Dec 2002
Pg. 415-417

Benzalkonium Chloride 1:750 Solution for Cold Disinfection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 448

Furosemide 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 453

Phenobarbital Sodium 130-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 457

Cleaning and Disinfection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 466-467

Sterilization of Talc for Use in Pleurodesis
Fehr Richard
, Henke Michelle, Ashworth Lisa D
Mar/Apr 2002
Pg. 140-141

New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems
Kastango Eric S
, Hadaway Lynn
Jan/Feb 2002
Pg. 55-57

Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures
Karolchyk Scott
Nov/Dec 2001
Pg. 422-423

Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution
Allen Loyd V Jr
Nov/Dec 2001
Pg. 455

New Perspectives on Vancomycin Use in Home Care, Part 1
Kastango Eric S
, Hadaway Lynn
Nov/Dec 2001
Pg. 465-469

Cross-contamination in Porcelain Mortars
Bauer-Brandl Annette
, Falck Astrid, Ingebrigtsen Lars, Nilsen Cathrina
Nov/Dec 2001
Pg. 476-479

Quality Assurance for Sterile Products
Kastango Eric S
, Douglass Kate
Jul/Aug 2001
Pg. 246-253

Sterile Compounding with Barrier-Isolation Technology
Rahe Hank
Jul/Aug 2001
Pg. 254-258

Bacterial Endotoxins and Pyrogens
Jones Marty
Jul/Aug 2001
Pg. 259-263

Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices"
Okeke Claudia C
, Barletta Frank, Newton David W, Allen Loyd V Jr
Jul/Aug 2001
Pg. 265-267

Sterile Compounding: Excerpts from the Reviews of Current Published Literature
MacCara Mary E
Jul/Aug 2001
Pg. 278-279

Analytical Testing Facilities and Products
Hudson Sonora
Jul/Aug 2001
Pg. 284-286

Maintenance of the Cleanroom
Allen Loyd V Jr
Jul/Aug 2001
Pg. 313

Sterile-Product Preparations: Mix or Buy?
Kastango Eric S
Jan/Feb 2001
Pg. 59-63

Short Communication: Compounding for Implantable Pumps
Molitor Richard
Jul/Aug 2000
Pg. 280

Dry Heat Sterilization of Parenteral Oil Vehicles
Kupiec Thomas C
, Matthews Parrish, Ahmad Riaz
May/Jun 2000
Pg. 223-224

Compounding Intrathecal Medications
Vidrine Eric
Jan/Feb 2000
Pg. 24-25

Standard Operating Procedure: Quality Assessment for Injectable Solutions
Allen Loyd V Jr
Sep/Oct 1999
Pg. 406-407

Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding
Kastango Eric S
, Douglass Kate
Jul/Aug 1999
Pg. 253-258

Sterilization and Depyrogenation Principles and Methods
Akers Michael J
Jul/Aug 1999
Pg. 263-269

Sterile Product Compounding: A Comparison of ASHP and USP Guidelines
Lima Hetty A
Jul/Aug 1999
Pg. 270-273

Y-Site Stability of Fosphenytoin and Sodium Phenobarbital
English Brett A
, Riggs Robert M, Webster Andrew A, Benner Kimberly W
Jan/Feb 1999
Pg. 64-66

Testing for Bacterial Endotoxins
Jelinek Todd
Sep/Oct 1998
Pg. 379

Ophthalmic Compounding: Techniques for Achieving Sterility
Leiter Charles W
May/Jun 1998
Pg. 189

Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations
Allen Loyd V Jr
May/Jun 1998
Pg. 192-195

An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate
Rice Stephen P
May/Jun 1998
Pg. 214-215

General Aseptic Procedures Used at a Laminar Airflow Workbench
Allen Loyd V Jr
May/Jun 1998
Pg. 242

Return to Top